Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women's Hospital in China: Analysis of 1,248,785 Pap Test Reports

被引:10
作者
Tao, Xiang [1 ]
Austin, R. Marshall [2 ]
Zhang, Hao [1 ]
Zhang, Lihong [1 ]
Xiao, Jianan [1 ]
Wang, Li [1 ]
Zhou, Xianrong [1 ]
Zhao, Chengquan [1 ,2 ]
机构
[1] Hosp Fudan Univ, Dept Pathol Obstet & Gynecol, Shanghai 200011, Peoples R China
[2] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Dept Pathol, 300 Halket St, Pittsburgh, PA 15213 USA
关键词
Cervical Pap test; Cervical cancer; The Bethesda System reporting rate; Liquid-based cytology; Conventional Pap; China;
D O I
10.1159/000443679
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: The Obstetrics and Gynecology Hospital of Fudan University (OGHFU) in Shanghai is the largest academic women's hospital in China. Between 2009 and 2014, the use of liquid-based cytology (LBC) significantly increased while gradually adopting the Bethesda System (TBS), and in 2012 local regulations mandated that pathologists replace technicians to sign out Pap tests. Design: A retrospective OGHFU database search documented all Pap test reports between 2009 and 2014 by specimen type, either LBC or conventional Pap smears (CPS), and final reporting category. A total of 1,224,785 Pap reports were analyzed to document variations in Pap test reporting during a period of major change in cervical screening in China. Results: LBC gradually replaced CPS, which declined from over 65% of Pap tests in 2010 to 6.4% in 2014. Of 514,811 Pap reports using the traditional class system, class I (negative) reports accounted for 98.3% of results. With the introduction of TBS reporting, pathologist reviews and substantial replacement of CPS by LBC, the laboratory abnormal Pap test rate increased significantly to almost 5%. Conclusions: Changes in cervical cytology reporting between 2009 and 2014 in China's largest academic women's hospital reflected both increased use of LBC and the introduction of pathologist TBS reporting. Abnormality rates increased significantly and fell within CAP benchmark ranges. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:445 / 451
页数:7
相关论文
共 21 条
[1]   Global estimates of cancer prevalence for 27 sites in the adult population in 2008 [J].
Bray, Freddie ;
Ren, Jian-Song ;
Masuyer, Eric ;
Ferlay, Jacques .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) :1133-1145
[2]   The impact of HPV vaccination delays in China: Lessons from HBV control programs [J].
Colombara, Danny V. ;
Wang, Shao-Ming .
VACCINE, 2013, 31 (38) :4057-4059
[3]   ACCOMPLISHMENTS AND SHORTCOMINGS OF CANCER CYTOLOGY [J].
DAY, E .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1956, 63 (06) :1070-1078
[4]  
Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331
[5]  
Ferlay J, 2013, IARC CANCERBASE, V11
[6]   ARTISTIC: a randomised trial of-human-papillomavirus (HPV) testing in primary cervical screening [J].
Kitchener, H. C. ;
Almonte, M. ;
Gilham, C. ;
Dowie, R. ;
Stoykova, B. ;
Sargent, A. ;
Roberts, C. ;
Desai, M. ;
Peto, J. .
HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (51) :1-+
[7]   Epidemiological Features of Human Papillomavirus (HPV) Infection among Women Living in Mainland China [J].
Li, Jing ;
Huang, Rong ;
Schmidt, Johannes E. ;
Qiao, You-Lin .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) :4015-4023
[8]  
Li J, 2011, ASIAN PAC J CANCER P, V12, P1149
[9]  
Papanicolaou GN, 1954, ATLAS EXFOLIATIVE CY
[10]   ESTIMATING PREVALENCE FROM RESULTS OF A SCREENING-TEST [J].
ROGAN, WJ ;
GLADEN, B .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1978, 107 (01) :71-76